Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milestone ScientificMLSS -10.47%37 Days Payable is 206.95 as of Jun. 2026, which is 65% above its 10-year median of 125.06. GuruFocus rates MLSS with a GF Score™ of 37/100 and a GF Value™ of $0.60 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Milestone Scientific ranks better than 87.15% on this metric.
The historical rank and industry rank for Milestone Scientific's Days Payable or its related term are showing as below:
MLSS'
s Days Payable Range Over the Past 10 Years
Min: 57.73 Med: 125.06 Max: 237.35
Current: 237.35
During the past 13 years, Milestone Scientific's highest Days Payable was 237.35. The lowest was 57.73. And the median was 125.06.
MLSS's Days Payable is ranked better than 87.15% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 68.615
vs MLSS: 237.35
Milestone Scientific's Days Payable
declined
from Jun. 2025 (218.03) to Jun. 2026 (206.95).
It may suggest that Milestone Scientificaccelerated paying its suppliers.
The historical data trend for Milestone Scientific's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Milestone Scientific's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milestone Scientific Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Days Payable distribution charts can be found below:
* The bar in red indicates where Milestone Scientific's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Milestone Scientific's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milestone Scientific (MLSS) has a Days Payable of 206.95 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Milestone Scientific and its competitors. This is 65% above median its historical median of 125.06. Over the past decade, Milestone Scientific's Days Payable has ranged from 57.73 to 237.35. According to the industry distribution chart, Milestone Scientific ranks #102 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 12.8%.
Is Milestone Scientific's Days Payable too high?
Milestone Scientific's current Days Payable of 206.95 is 65% above median its 10-year median of 125.06. Over the past 10 years, this metric has ranged from a low of 57.73 to a high of 237.35. The Medical Devices & Instruments industry median Days Payable is 68.62. Milestone Scientific's value of 206.95 is 201.6% above this industry median. Based on the distribution chart, Milestone Scientific ranks #102 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Milestone Scientific has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Milestone Scientific's Days Payable compare to NEPH and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Milestone Scientific ranks #102 out of 794 companies for Days Payable. This places Milestone Scientific in the top 13% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.62. Milestone Scientific's value of 206.95 is 201.6% above this benchmark. Historically, Milestone Scientific's own Days Payable has ranged from 57.73 to 237.35 over the past decade. While the company's 10-year median is 125.06 vs. the industry median of 68.62, Milestone Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.62, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Milestone Scientific's current Days Payable of 206.95 is 201.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Milestone Scientific and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milestone Scientific's current Days Payable is 206.95, which is 65% above median its own 10-year median of 125.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Scientific stock overvalued right now?
Based on GuruFocus' analysis, Milestone Scientific (MLSS) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.60, compared to a current price of $0.50 — trading 17.5% below its estimated fair value. The current Days Payable is 206.95, which is 65% above median its 10-year median of 125.06 and 201.6% above the Medical Devices & Instruments industry median of 68.62. Milestone Scientific's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Milestone Scientific (MLSS), the current Days Payable is 206.95 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Milestone Scientific (MLSS) Overvalued in 2026?
Based on GuruFocus' analysis, Milestone Scientific stock appears to be undervalued.
The current stock price of $0.50 is trading 17.5% below its estimated GF Value™ of $0.60.
GuruFocus considers Milestone Scientific to be Modestly Undervalued.
Key valuation signals for MLSS:
Days Payable: 206.95 (65% above median its 10-year median of 125.06)
GF Value™: $0.60 vs. price of $0.50 (17.5% below fair value)
Industry Position: 201.6% above the Medical Devices & Instruments median (#102 of 794)
No single metric tells the full story. See the MLSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
37GF Score
Get the complete analysis for MLSS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLSS has been successfully added to your 
